Management of Restless Leg Syndrome During Suboxone Taper

First-Line Approach During Suboxone Taper

• The American Academy of Sleep Medicine recommends maintaining the current buprenorphine (Suboxone) regimen as it has dual benefit of managing both opioid use disorder and RLS symptoms, with a reduced risk of respiratory depression compared to other opioids 1, 2, 3
• Consider slowing the taper schedule if RLS symptoms become severe, as buprenorphine itself is effective for RLS management 2, 3

Adjunctive Therapies During Taper

• Add alpha-2-delta ligands (gabapentin, pregabalin) as first-line adjunctive therapy if RLS symptoms worsen during taper 4
• Consider iron supplementation if ferritin levels are low or transferrin saturation is low, preferably with IV ferric carboxymaltose for more rapid effect 4

Medications to Avoid

• Avoid sedating medications that may compound respiratory risks when combined with opioids 1, 2

Special Considerations

• The American Academy of Sleep Medicine notes that buprenorphine has a reduced risk of respiratory depression compared to other opioids used for RLS 1, 2, 3
• Long-term studies of opioid use for RLS show relatively low risks of abuse and overdose in appropriately screened patients 2, 3
• Patients typically show only small dose increases in opioid requirements over extended periods when used specifically for RLS management 2, 3